menu
    • menu

    Company profile for Zenith Epigenetics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Zenith Epigenetics Ltd. ("Zenith Epigenetics") is a clinical stage biotechnology company developing best in class bromodomain and extraterminal domain protein (BET) inhibitors for the treatment of cancer and other disorders with significant unmet medical need. Our cutting edge epigenetic platform of innovative biology and chemistry has generated differentiated, potent and selective BET inhibitors. Our goal is to be a leading e...
    Zenith Epigenetics Ltd. ("Zenith Epigenetics") is a clinical stage biotechnology company developing best in class bromodomain and extraterminal domain protein (BET) inhibitors for the treatment of cancer and other disorders with significant unmet medical need. Our cutting edge epigenetic platform of innovative biology and chemistry has generated differentiated, potent and selective BET inhibitors. Our goal is to be a leading epigenetic company translating bromodomain biology into impactful therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zenith EpigeneticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Suite 4010, 44 Montgomery Street San Francisco, CA 94104
    Telephone
    Telephone
    (415) 470-5600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.zenithepigenetics.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/zenith-epigenetics-corp-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/zenithepi

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zenith Epigenetics Announces Start of Several NCI-Sponsored Oncology Trials
    Zenith Epigenetics Announces Start of Several NCI-Sponsored Oncology Trials

    06 Jul 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/07/06/2474791/0/en/Zenith-Epigenetics-Announces-Start-of-Several-National-Cancer-Institute-NCI-Sponsored-Oncology-Clinical-Trials.html

    GLOBENEWSWIRE
    06 Jul 2022
    Share Share
    Zenith Epigenetics TNBC Clinical Data Highlighted in an Oral Discussion at ASCO
    Zenith Epigenetics TNBC Clinical Data Highlighted in an Oral Discussion at ASCO

    21 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/21/2465992/0/en/Zenith-Epigenetics-Triple-Negative-Breast-Cancer-Clinical-Data-Highlighted-in-an-Oral-Discussion-at-the-American-Society-of-Clinical-Oncology-Conference-ASCO.html

    GLOBENEWSWIRE
    21 Jun 2022
    Share Share
    Zenith commences Phase IIb breast cancer combination therapy trial
    Zenith commences Phase IIb breast cancer combination therapy trial

    11 May 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/zenith-breast-cancer-trial/

    CLINICALTRIALSARENA
    11 May 2022
    Share Share
    Zenith Epigenetics Announces Initiation of PIIb TNBC Trial
    Zenith Epigenetics Announces Initiation of PIIb TNBC Trial

    10 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/10/2439733/0/en/Zenith-Epigenetics-Announces-Initiation-of-a-Phase-2b-Triple-Negative-Breast-Cancer-TNBC-Clinical-Trial.html

    GLOBENEWSWIRE
    10 May 2022
    Share Share
    Zenith Epigenetics Begins Dosing of Combination of ZEN-3694 + BMS' OPDIVO
    Zenith Epigenetics Begins Dosing of Combination of ZEN-3694 + BMS' OPDIVO

    22 Feb 2022

    // BIOSPACE

    https://www.biospace.com/article/releases/zenith-epigenetics-announces-dosing-of-first-cancer-patient-with-a-combination-of-zen-3694-bristol-myers-squibb-s-immune-checkpoint-inhibitor-opdivo/

    BIOSPACE
    22 Feb 2022
    Share Share
    Zenith Epigenetics Announces a Publication in the Journal of Cancer Gene Therapy
    Zenith Epigenetics Announces a Publication in the Journal of Cancer Gene Therapy

    17 Aug 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/08/17/2281942/0/en/Zenith-Epigenetics-Announces-a-Publication-in-the-Journal-of-Cancer-Gene-Therapy-with-Compelling-Data-for-the-Treatment-of-ER-Positive-Breast-Cancer-Patients.html

    GLOBENEWSWIRE
    17 Aug 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search